Publication Beamlines Strategic Pillar
(2018). . Patent Number: NO2968312T3.
(2018). Antibody polypeptides that antagonize cd40. Patent Number: IL228720B.
(2018). Methods and compositions. Patent Number: GB201817444D0.
(2018). . Patent Number: NO2699601T3.
(2018). Antibody epitope. Patent Number: IL256097A.
(2013). Fc VARIATIONS AND METHODS FOR PRODUCTION. Patent Number: AR085138A1.
(2013). ANTIBODY POLYPEPTIDES ANTAGONIZING CD40. Patent Number: AR086360A1.
(2018). Antibodies to the bradykinin b1 receptor. Patent Number: IL234830B.
(2014). ANTIBODIES AGAINST BRADICININE B1 RECEIVER LIGANDS. Patent Number: AR090352A1.
(2018). Anti-hemagglutinin antibodies and methods of use. Patent Number: IL263320A.
(2017). ANTI-BCMA ANTIBODIES (CELL MATURATION ANTIGEN B), BINDING SPECIFIC MOLECULES THAT JOIN BCMA AND CD3 (AGGREGATE DETERMINANT 3), AND USES OF THESE. Patent Number: AR105724A1.
(2015). Anti-hemagglutinin antibodies and methods of use. Patent Number: IL238684A0.
(2015). ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE. Patent Number: AR093446A1.
(2015). Novel TNFa structure for use in therapy. Patent Number: GB201510758D0.
(2010). Goldschmidt Abstracts 2010 – B. Geochimica et Cosmochimica Acta 74(12) , A38-A134. 10.1016/j.gca.2010.04.027. SM